EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

Glucocorticoid therapy as first-line treatment in primary hypophysitis: a systematic review and individual patient data meta-analysis

Brijesh Krishnappa iD, Ravikumar Shah iD, Saba Samad Memon, Chakra Diwaker, Anurag R Lila iD, Virendra A Patil, Nalini S Shah, Tushar R Bandgar iD

Endocrine Connections · 01.02.2023 · 12 (2)

DOI: 10.1530/ec-22-0311 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Endocrine Connections, erschienen am 01.02.2023. Verfasst von Brijesh Krishnappa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, K E M Hospital and Seth G S Medical College, Mumbai, India. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

High-dose glucocorticoids are associated with improved recovery of deficits in primary autoimmune hypophysitis (PAH), but optimal dosing, route, and duration are unclear.

Design

We reviewed literature for first-line glucocorticoid treatment in PAH until December 2021 and performed an individual patient data meta-analysis to analyze clinical, hormonal, and radiological outcomes with respect to route, dose, and duration (12 weeks) of glucocorticoid treatment according to disease severity.

Results

A total of 153 PAH patients from 83 publications were included. The median age at presentation was 41 (32.5–48) years with a female preponderance (70.3%). Visual field recovery was significantly better with i.v. (91.7%) as compared to oral (54.5%) route and high dose (100%) and very high dose (90.9%) as compared to medium dose (20%) of glucocorticoids. Corticotroph axis recovery was greater in i.v. (54.8% vs 28.1% oral, P = 0.033) route and increasing glucocorticoid dose group (0% vs 38.1% vs 57.1%), attaining statistical significance ( P = 0.012) with very high-dose. A longer duration of treatment (>6.5 weeks) was associated with better corticotroph and thyrotroph recovery. The need for rescue therapy was lower with i.v. route (38% vs 17.5%, P = 0.012) and with increasing glucocorticoid doses (53.3% vs 34.3% vs 17.3%, P = 0.016). In severe disease, visual field and corticotroph axis recovery were significantly higher with i.v. route and very high-dose steroids. The adverse effects of glucocorticoids were independent of dose and duration of treatment.

Conclusions

Very high-dose glucocorticoids by i.v. route and cumulative longer duration (>6.5 weeks) lead to better outcomes and could be considered as first-line treatment of severe PAH cases.

Schlagwörter

Stichwörter der Autor:innen

duration of treatmentintravenous glucocorticoidsneed for rescue therapyprimary autoimmune hypophysitisvery high-dose glucocorticoids

Autor:innen und Institutionen

  • Department of Endocrinology, K E M Hospital and Seth G S Medical College, Mumbai, India.

ORCID-Profile: Brijesh Krishnappa, Ravikumar Shah, Anurag R Lila, Tushar R Bandgar

Zitieren

APA

Krishnappa, B., Shah, R., Memon, S. S., Diwaker, C., Lila, A. R., Patil, V. A., Shah, N. S., & Bandgar, T. R. (2023). Glucocorticoid therapy as first-line treatment in primary hypophysitis: a systematic review and individual patient data meta-analysis. Endocrine Connections, 12(2). https://doi.org/10.1530/ec-22-0311

Vancouver

Krishnappa B, Shah R, Memon SS, Diwaker C, Lila AR, Patil VA, et al. Glucocorticoid therapy as first-line treatment in primary hypophysitis: a systematic review and individual patient data meta-analysis. Endocrine Connections. 2023;12(2). doi:10.1530/ec-22-0311

BibTeX
@article{Krishnappa2023,
  author = {Krishnappa, Brijesh and Shah, Ravikumar and Memon, Saba Samad and Diwaker, Chakra and Lila, Anurag R and Patil, Virendra A and Shah, Nalini S and Bandgar, Tushar R},
  title = {Glucocorticoid therapy as first-line treatment in primary hypophysitis: a systematic review and individual patient data meta-analysis},
  journal = {Endocrine Connections},
  year = {2023},
  volume = {12},
  number = {2},
  doi = {10.1530/ec-22-0311}
}
Kostenlos starten →